Finally, dysregulated legumain activity is associated with cancer and neurodegenerative diseases, including Alzheimer's disease (AD), stroke, ischemia, amyotrophic lateral sclerosis (ALS), and multiple sclerosis [39, 40]. This evidence concerns the gene LGMN and amyotrophic lateral sclerosis.